Wang M - Search Results

1

Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures.

Banerjee NS, Rivera AA, Wang M, Chow LT, Broker TR, Curiel DT, Nettelbeck DM. Banerjee NS, et al. Among authors: wang m. Mol Cancer Ther. 2004 Apr;3(4):437-49. Mol Cancer Ther. 2004. PMID: 15078987

2

A model system for the design of armed replicating adenoviruses using p53 as a candidate transgene.

Haviv YS, Takayama K, Glasgow JN, Blackwell JL, Wang M, Lei X, Curiel DT. Haviv YS, et al. Among authors: wang m. Mol Cancer Ther. 2002 Mar;1(5):321-8. Mol Cancer Ther. 2002. PMID: 12489848

3

Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.

Zhu ZB, Makhija SK, Lu B, Wang M, Kaliberova L, Liu B, Rivera AA, Nettelbeck DM, Mahasreshti PJ, Leath CA, Barker S, Yamaoto M, Li F, Alvarez RD, Curiel DT. Zhu ZB, et al. Among authors: wang m. Cancer Gene Ther. 2004 Apr;11(4):256-62. doi: 10.1038/sj.cgt.7700679. Cancer Gene Ther. 2004. PMID: 15017380

4

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.

Kanerva A, Wang M, Bauerschmitz GJ, Lam JT, Desmond RA, Bhoola SM, Barnes MN, Alvarez RD, Siegal GP, Curiel DT, Hemminki A. Kanerva A, et al. Among authors: wang m. Mol Ther. 2002 Jun;5(6):695-704. doi: 10.1006/mthe.2002.0599. Mol Ther. 2002. PMID: 12027553 Free article.

5

Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors.

Haviv YS, Blackwell JL, Kanerva A, Nagi P, Krasnykh V, Dmitriev I, Wang M, Naito S, Lei X, Hemminki A, Carey D, Curiel DT. Haviv YS, et al. Among authors: wang m. Cancer Res. 2002 Aug 1;62(15):4273-81. Cancer Res. 2002. PMID: 12154029

6

Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression.

Hemminki A, Kanerva A, Liu B, Wang M, Alvarez RD, Siegal GP, Curiel DT. Hemminki A, et al. Among authors: wang m. Cancer Res. 2003 Feb 15;63(4):847-53. Cancer Res. 2003. PMID: 12591736

7

Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids.

Lam JT, Bauerschmitz GJ, Kanerva A, Barker SD, Straughn JM, Wang M, Barnes MN, Blackwell JL, Siegal GP, Alvarez RD, Curiel DT, Hemminki A. Lam JT, et al. Among authors: wang m. Cancer Gene Ther. 2003 May;10(5):377-87. doi: 10.1038/sj.cgt.7700578. Cancer Gene Ther. 2003. PMID: 12719707

8

Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potential.

Hemminki A, Wang M, Hakkarainen T, Desmond RA, Wahlfors J, Curiel DT. Hemminki A, et al. Among authors: wang m. Cancer Gene Ther. 2003 Aug;10(8):583-8. doi: 10.1038/sj.cgt.7700606. Cancer Gene Ther. 2003. PMID: 12872139

9

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer.

Yamamoto M, Davydova J, Wang M, Siegal GP, Krasnykh V, Vickers SM, Curiel DT. Yamamoto M, et al. Among authors: wang m. Gastroenterology. 2003 Oct;125(4):1203-18. doi: 10.1016/s0016-5085(03)01196-x. Gastroenterology. 2003. PMID: 14517802

10

Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo.

Rivera AA, Wang M, Suzuki K, Uil TG, Krasnykh V, Curiel DT, Nettelbeck DM. Rivera AA, et al. Among authors: wang m. Virology. 2004 Mar 1;320(1):121-34. doi: 10.1016/j.virol.2003.11.028. Virology. 2004. PMID: 15003868 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62,148 results

Search Page